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INTRODUCTION
CLINICAL CASE
DISCUSSION
Paroxysmal Dyskinesia (PD) is a group of diseases of the central
nervous system1. They are characterized by an abnormal
involuntary motor activity and an increase in muscle tone
without presenting autonomous signs, EEG abnormalities or
changes in the state of consciousness1, 2, 3.
Even though multiple etiologies of PD are described1, this study
is focused on the approach to Paroxysmal Gluten Sensitive
Dyskinesia (PGSD).
A 11-year-old mixed-breed, spayed
female was presented for chronic
and intermittent digestive signs and
neurological alterations.
❖Physical exam: Body condition
(4/9) and presence pasty faeces on
anal palpation. A neurological
exam was also perform, which was
completely normal.
❖CBC and biochemistry:
Table 1.
❖Thorax X-ray and
abdominal ultrasound:
No abnormalities.
❖Owner’s video record:
Fig. 1.
❖Intracranial MRI and
CSF: No abnormalities.
❖Treatment: Dietary trial with an
hypoallergenic diet (Royal Canin).
❖Evolution: After 6
weeks of a exclusively
hypoallergenic diet, both
digestive and
neurological alterations
disappeared and body
condition was
recovered.
Value Reference range
Total Proteins 4,41 g/dL 5,6 – 7,5 g/dL
Alkaline
phosphatase
14,47 UI/L 20 – 156 UI/L
Potassium 3,99 mmol/L 4,37 – 5,35 mmol/L
Table 1. Analytical values outside the reference range
Figure 1. QR code showing movement
alterations
PGSD is the first alteration of movement that has a serological
relationship with gluten2, 4. It can be presented in the Border
and Yorkshire Terrier 4, 5. It is associated with cutaneous,
neurological and digestive clinical signs 2, 3, 4.
The diagnosis is made by excluding other causes of dyskinesia,
recognition of the video recording and through a dietary trial
based on a gluten-free diet (Fig. 2) 6,7.
Recently, serological tests (ELISA) have been described that
analyse antitransglutaminase-2 IgA antibody titter, but it has
limited availability in veterinary medicine 6,7.
Figure 2. Graph showing the decrease of the antibody levels
against antitransglutaminase-2 IgA depending on how much time
the patient has been on a gluten-free diet (Lowrie et al. 2015)
CONCLUSION
The pathophysiology of PGSD in veterinary medicine has not
been fully described yet, since additional studies are required
to determine if the clinical manifestations are related to the
same disease in humans.
The treatment of choice is a gluten-free diet.
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OBJECTIVES
1. Describe a clinical case of PGSD.
2. Bibliographic review of PGSD.
